216 related articles for article (PubMed ID: 29093491)
1. Dosimetric comparison of the helical tomotherapy, volumetric-modulated arc therapy and fixed-field intensity-modulated radiotherapy for stage IIB-IIIB non-small cell lung cancer.
Xu Y; Deng W; Yang S; Li P; Kong Y; Tian Y; Liao Z; Chen M
Sci Rep; 2017 Nov; 7(1):14863. PubMed ID: 29093491
[TBL] [Abstract][Full Text] [Related]
2. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H
Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536
[TBL] [Abstract][Full Text] [Related]
3. [Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer].
Xu YJ; Li P; Hu X; Wang J; Ma HL; Chen M
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3260-3265. PubMed ID: 31694123
[No Abstract] [Full Text] [Related]
4. Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma.
Zhang Y; Wang H; Huang X; Zhang Q; Ren R; Sun R; Zheng Z; Dong S; Zheng A
Med Dosim; 2019 Summer; 44(2):167-172. PubMed ID: 29950277
[TBL] [Abstract][Full Text] [Related]
5. Compared planning dosimetry of TOMO, VMAT and IMRT in rectal cancer with different simulated positions.
Lin JC; Tsai JT; Chen LJ; Li MH; Liu WH
Oncotarget; 2017 Jun; 8(26):42020-42029. PubMed ID: 28159930
[TBL] [Abstract][Full Text] [Related]
6. Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Wang X; Tian Y; Tang Y; Hu ZH; Zhang JJ; Fu GS; Ma P; Ren H; Zhang T; Li N; Liu WY; Fang H; Li YX; Jin J
Oncotarget; 2017 Jun; 8(24):39727-39735. PubMed ID: 28061474
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy and volumetric-modulated arc therapy have distinct clinical advantages in non-small cell lung cancer treatment.
Zhang J; Yu XL; Zheng GF; Zhao F
Med Oncol; 2015 Apr; 32(4):94. PubMed ID: 25725813
[TBL] [Abstract][Full Text] [Related]
8. Planning analysis for locally advanced lung cancer: dosimetric and efficiency comparisons between intensity-modulated radiotherapy (IMRT), single-arc/partial-arc volumetric modulated arc therapy (SA/PA-VMAT).
Jiang X; Li T; Liu Y; Zhou L; Xu Y; Zhou X; Gong Y
Radiat Oncol; 2011 Oct; 6():140. PubMed ID: 22014217
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer.
Meng LL; Feng LC; Wang YL; Dai XK; Xie CB
Chin Med J (Engl); 2011 Jun; 124(11):1667-71. PubMed ID: 21740774
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Flattening Filter Free on Three-dimensional Conformal Radiation Therapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT) Plans for Metastatic Brain Tumors from Non-small Cell Lung Cancer.
Shi LW; Lai YQ; Lin Q; Ha HM; Fu LR
Health Phys; 2015 Jul; 109(1):1-9. PubMed ID: 26011493
[TBL] [Abstract][Full Text] [Related]
11. Optimal tumor coverage with different beam energies by IMRT, VMAT and TOMO: Effects on patients with proximal gastric cancer.
Huang SF; Lin JC; Shiau AC; Chen YC; Li MH; Tsai JT; Liu WH
Medicine (Baltimore); 2020 Nov; 99(47):e23328. PubMed ID: 33217871
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus TomoTherapy.
Xhaferllari I; El-Sherif O; Gaede S
J Appl Clin Med Phys; 2016 Sep; 17(5):329-340. PubMed ID: 27685129
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Dosimetric Benefits of Three Precise Radiotherapy Techniques in Nasopharyngeal Carcinoma Patients Using a Priority-Classified Plan Optimization Model.
Wang Q; Qin J; Cao R; Xu T; Yan J; Zhu S; Wu J; Xu G; Zhu L; Jiang W; Li W; Xiong W
Front Oncol; 2021; 11():646584. PubMed ID: 34646757
[TBL] [Abstract][Full Text] [Related]
15. Normal lung sparing Tomotherapy technique in stage III lung cancer.
Hong CS; Ju SG; Ahn YC; Yoo GS; Noh JM; Oh D; Chung K; Pyo H; Jo K
Radiat Oncol; 2017 Nov; 12(1):167. PubMed ID: 29110732
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
17. Impact of four-dimensional computed tomography pulmonary ventilation imaging-based functional avoidance for lung cancer radiotherapy.
Yamamoto T; Kabus S; von Berg J; Lorenz C; Keall PJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):279-88. PubMed ID: 20646852
[TBL] [Abstract][Full Text] [Related]
18. Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.
Sun T; Lin X; Tong Y; Liu X; Pan L; Tao C; Duan J; Yin Y
Front Oncol; 2019; 9():1456. PubMed ID: 31998635
[No Abstract] [Full Text] [Related]
19. Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma.
Liu X; Huang E; Wang Y; He Y; Luo H; Zhong M; Qiu D; Li C; Yang H; He G; Zhou J; Jin F
Radiat Oncol; 2017 Apr; 12(1):76. PubMed ID: 28449713
[TBL] [Abstract][Full Text] [Related]
20. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT.
Lu SH; Cheng JC; Kuo SH; Lee JJ; Chen LH; Wu JK; Chen YH; Chen WY; Wen SY; Chong FC; Wu CJ; Wang CW
Radiother Oncol; 2012 Sep; 104(3):324-30. PubMed ID: 22236614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
